13 research outputs found
Influenza vaccination induces NK-cell-mediated type-II IFN response that regulates humoral immunity in an IL-6-dependent manner
The role of natural killer (NK) cells in the immune response against vaccines is not fully understood. Here, we examine the function of infiltrated NK cells in the initiation of the inflammatory response triggered by inactivated influenza virus vaccine in the draining lymph node (LN). We observed that, following vaccination, NK cells are recruited to the interfollicular and medullary areas of the LN and become activated by type I interferons (IFNs) produced by LN macrophages. The activation of NK cells leads to their early production of IFNγ, which in turn regulates the recruitment of IL-6+ CD11b+ dendritic cells. Finally, we demonstrate that the interleukin-6 (IL-6)-mediated inflammation is important for the development of an effective humoral response against influenza virus in the draining LN
Macrophage death following influenza vaccination initiates the inflammatory response that promotes dendritic cell function in the draining lymph node
The mechanism by which inflammation influences the adaptive response to vaccines is not fully understood. Here, we examine the role of lymph node macrophages (LNMs) in the induction of the cytokine storm triggered by inactivated influenza virus vaccine. Following vaccination, LNMs undergo inflammasome-independent necrosis-like death that is reliant on MyD88 and Toll-like receptor 7 (TLR7) expression and releases pre-stored interleukin-1α (IL-1α). Furthermore, activated medullary macrophages produce interferon-β (IFN-β) that induces the autocrine secretion of IL-1α. We also found that macrophage depletion promotes lymph node-resident dendritic cell (LNDC) relocation and affects the capacity of CD11b+ LNDCs to capture virus and express co-stimulatory molecules. Inhibition of the IL-1α-induced inflammatory cascade reduced B cell responses, while co-administration of recombinant IL-1α increased the humoral response. Stimulation of the IL-1α inflammatory pathway might therefore represent a strategy to enhance antigen presentation by LNDCs and improve the humoral response against influenza vaccines
A detailed immunohistochemical analysis of the PI3K/AKT/mTOR pathway in lung cancer: Correlation with PIK3CA, AKT1, K-RAS or PTEN mutational status and clinicopathological features
The phosphoinositide 3-kinase (PI3K)/v-akt murine thymoma viral oncogene
homolog (AKT)/mammalian target of rapamycin (mTOR) pathway is
upregulated in a number of human cancers, including non-small cell lung
cancer (NSCLC). Its potential role in NSCLC progression provides an
attractive target for anticancer therapy. The expression of
phosphorylated mTOR (p-mTOR), phosphorylated AKT (p-AKT), p85 alpha and
p110 gamma subunits of PI3K, phosphorylated p70S6K (p-p70S6K),
phosphatase and tensin homolog (PTEN) and phosphorylated 4E-BP1
(p-4E-BP1) was examined by immunohistochemistry in 102 NSCLC specimens.
The results were correlated with clinicopathological features. We also
examined 61 of our cases for the presence of PIK3CA, AKT1, PTEN and
K-RAS mutations. A common PIK3CA mutation was detected at exon 9 in 2
samples (p.E545K), whereas another sample displayed a rare mutation
(p.D1018N). Furthermore, 10 out of 54 cases (18.5%) had a K-RAS
mutation at codon 12, 5 had a PTEN mutation (exons 7 and 8) and 1 case
had an AKT1 mutation (p.E17K). PTEN mutations were associated with nodal
metastases. The expression of p-mTOR positively correlated with that of
p-AKT and p-p70S6K and was higher in adenocarcinomas along with nuclear
p110 gamma PI3K expression, whereas p-4E-BP1 expression was higher in
squamous cell carcinomas. We also established a positive association
between p85 alpha PI3K or p110 gamma PI3K and cytoplasmic p-AKT and its
downstream effectors. An inverse correlation was noted between p-4E-BP1
immunoexpression and tumour status and nuclear p-AKT expression as
regards tumour stage. Univariate survival analysis demonstrated that
p-4E-BP1 expression, either alone or in combination with cytoplasmic
p-AKT expression had an adverse prognostic significance in
adenocarcinomas. The combination of p-4E-BP1 and cytoplasmic p-AKT
expression remained significant in the multivariate analysis as a
function of their interaction with histological type. Our data
demonstrate the significance of p-4E-BP1 immunoexpression as a molecular
marker of prognostic value in adenocarcinomas, particularly when
combined with p-AKT
Antimüllerian Hormone as a Tool to Predict the Age at Menopause
This study aimed to assess an eligible cut-off value of anti-Müllerian hormone (AMH) to detect ovarian senescence in a group of premenopausal Greek women to evaluate the possible link between AMH-values and the severity of climacteric symptoms during a follow-up of 24 months. This study included 180 women (group A, 96 women of late reproductive stage/early perimenopause; group B, 84 women in late perimenopause). We measured AMH blood levels and assessed climacteric symptoms using the Greene scale. Log-AMH is inversely associated with postmenopausal status. The AMH cut-off of 0.012 ng/mL predicts the postmenopausal status with a sensitivity of 24.2% and specificity of 30.5%. The postmenopausal stage associated with age (OR = 1.320, 95%CI: 1.084–1.320) and AMH (values ≥ vs. p-value p-value = 0.027). In conclusion, AMH levels measured in the late premenopausal period are inversely associated with the time to ovarian senescence. In contrast, AMH levels measured in the perimenopausal period are inversely associated only with the severity of VMS. Therefore, a cut-off of 0.012 ng/mL predicts menopause with low sensitivity and specificity, making it challenging to use in a clinical setting
mRNA coexpression patterns of Wnt pathway components and their clinicopathological associations in breast and colorectal cancer
Aberrant Wnt signaling is implicated in carcinogenesis triggering
efforts for the development of new therapeutic agents, many of which
have entered clinical trials. We extend our previous analysis of WNT3,
FZD7, LEFI expression levels in breast and colorectal cancer including
WNT2, FZD4 and beta-catenin expression, in an effort to delineate their
relative expression levels along with concurrent expression patterns and
possible prognostic value. We analyzed 82 breast and 102 colorectal
carcinomas for relative mRNA expression levels of the investigated genes
by RT-PCR relative quantification with the Delta Delta Ct method.
Statistical analysis was performed in order to determine associations of
relative mRNA expression and linear correlations. beta-catenin
expression was determined by immunochemistry. Regarding breast
carcinomas, decreased relative mRNA expression levels of WNT2, FZD4 were
found frequently and WNT2 expression was correlated with ER/ PR status
(p = 0.045/p = 0.028), whereas beta-catenin with grade (p = 0.026). In
colorectal carcinomas, increased relative mRNA expression levels of WNT2
and FZD4 were found in 59% and 32% of cases respectively, whereas
beta-catenin showed decreased mRNA expression levels in 57% of cases
and a correlation with pN-category (p = 0.037). Linear correlations were
observed between WNT2/FZD4 (R=0.542, p < 0.001), WNT2/beta-catenin
(R=0.254, p = 0.010), FZD4/beta-catenin (R=0.406, p < 0.001) expression
and a correlation between mRNA expression and membranous/cytoplasmic
beta-catenin emerged (p = 0.039/0.046). Our results suggest a possible
clinical significance for Wnt pathway gene expression levels in both
tumour types. The concurrent expression of the investigated genes as
well as the different expression profiles, underlines the complexity of
this pathway and the necessity of patient selection in order to maximize
the efficacy of drugs targeting Wnt pathway
Raw Data TRAIL.xlsx
Cp raw data from real time RT-PCR experiments are included in this excel file<br
Macrophage Death following Influenza Vaccination Initiates the Inflammatory Response that Promotes Dendritic Cell Function in the Draining Lymph Node
The mechanism by which inflammation influences the adaptive response to vaccines is not fully understood. Here, we examine the role of lymph node macrophages (LNMs) in the induction of the cytokine storm triggered by inactivated influenza virus vaccine. Following vaccination, LNMs undergo inflammasome-independent necrosis-like death that is reliant on MyD88 and Toll-like receptor 7 (TLR7) expression and releases pre-stored interleukin-1α (IL-1α). Furthermore, activated medullary macrophages produce interferon-β (IFN-β) that induces the autocrine secretion of IL-1α. We also found that macrophage depletion promotes lymph node-resident dendritic cell (LNDC) relocation and affects the capacity of CD11b+ LNDCs to capture virus and express co-stimulatory molecules. Inhibition of the IL-1α-induced inflammatory cascade reduced B cell responses, while co-administration of recombinant IL-1α increased the humoral response. Stimulation of the IL-1α inflammatory pathway might therefore represent a strategy to enhance antigen presentation by LNDCs and improve the humoral response against influenza vaccines.ISSN:2666-3864ISSN:2211-124